Search

Your search keyword '"Endocarditis -- Risk factors"' showing total 5 results
Start Over Descriptor "Endocarditis -- Risk factors" Publisher elsevier b.v.
5 results on '"Endocarditis -- Risk factors"'

1. Analysis of mortality and risk factors associated with native valve endocarditis in drug users: The importance of vegetation size

Subjects
Endocarditis -- Risk factors, Endocarditis -- Health aspects, Cross infection -- Risk factors, Cross infection -- Health aspects, Nosocomial infections -- Risk factors, Nosocomial infections -- Health aspects, Cardiac patients -- Health aspects, Mortality, Health
Abstract

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.ahj.2005.02.009 Byline: Pilar Martin-Davila (a), Enrique Navas (a), Jesus Fortun (a), Jose Luis Moya (b), Javier Cobo (a), Vicente Pintado (a), Carmen Quereda (a), Manuel Jimenez-Mena (b), Santiago Moreno (a) Abstract: Native valve endocarditis in drug-user patients had a microbiology, a frequency of involvement of different cardiac valves, and a prognosis that differ from those in non-drug users. A retrospective study of native valve endocarditis cases in intravenous drug users diagnosed from 1985 to 1999 in our institution was performed to analyze the inhospital mortality of drug users with native valve endocarditis and to identify factors predictive of mortality. Author Affiliation: (a) Department of Infectious Diseases, Hospital Ramon y Cajal, Madrid, Spain (b) Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain Article History: Received 23 June 2004; Accepted 7 February 2005

Published
2005

2. Analysis of mortality and risk factors associated with native valve endocarditis in drug users: the importance of vegetation size

Author

Martin-Davila, Pilar, Navas, Enrique, Fortun, Jesus, Moya, Jose Luis, Cobo, Javier, Pintado, Vicente, Quereda, Carmen, Jimenez-Mena, Manuel, and Moreno, Santiago

Subjects
Endocarditis -- Patient outcomes, Endocarditis -- Risk factors, Heart valve diseases -- Research, Drug addicts -- Health aspects, Drug addicts -- Research, Mortality -- Risk factors, Health
Published
2005

4. Incidence and risk of developing fungal prosthetic valve endocarditis after nosocomial candidemia

Author

Nasser, Rana M., Melgar, Gerardo R., Longworth, David L., and Gordon, Steven M.

Subjects
Nosocomial infections -- Risk factors, Endocarditis -- Risk factors, Heart valve prosthesis -- Complications, Candidiasis -- Complications, Health, Health care industry
Abstract

PURPOSE: To determine the incidence of prosthetic valve endocarditis (PVE) in fungemic patients with prosthetic heart valves (PHV), estimate the risk of subsequent PVE, and describe risk factors and diagnostic and therapeutic management issues in such patients. PATIENTS AND METHODS: This is a retrospective chart review in a 1,100-bed tertiary referral center with an active cardiothoracic surgical service. Forty-four patients with PHVs developed nosocomial fungemia between January 1985 and April 1995. RESULTS: Of 44 patients, 33 never developed evidence of PVE (group 1), 7 (16%) had evidence of PVE at the time of candidemia (group 2), and 4 (9%) developed PVE a mean of 232 days after candidemia (group 3). Predisposing factors including intravascular lines, prior antibiotic therapy, and an identifiable portal of entry for fungemia were common in group 1 but not group 2. Candidemia occurred significantly later after PHV surgery in group 2 (mean 270 days) as compared to groups 1 and 3 (means 48 and 15.5 days, respectively; P = 0.02). Ten of 11 patients with Candida PVE (group 2 and 3) were treated with amphotericin B and valve replacement. Three relapses after combined therapy were documented in two patients. Mortality was significantly higher for patients without Candida PVE (group 1) as compared to patients with Candida PVE (groups 2 and 3) at 1 month (53% vs 9%), 2 months (69% vs 20%) and 1 year (83% vs 25%) after candidemia. CONCLUSIONS: Patients with prosthetic heart valves who develop nosocomial candidemia are at notable risk of either having or developing Candida PVE months or years later. Late onset candidemia and lack of an identifiable portal of entry should heighten concern about Candida PVE in such patients. Am J Med. 1997;103:25-32. [C] 1997 by Excerpta Medica, Inc.

Published
1997

5. Role of infections in atherosclerosis

Author

Valtonen, Ville V.

Subjects
Atherosclerosis -- Risk factors, Atherosclerosis -- Health aspects, Endocarditis -- Risk factors, Endocarditis -- Health aspects, Bacterial infections -- Risk factors, Bacterial infections -- Health aspects, Health
Abstract

Byline: Ville V. Valtonen Abstract: A growing amount of epidemiologic, experimental, and clinical evidence has linked infection as a risk factor to variousatherosclerotic diseases including acute myocardial infarction and cerebral infarction. Bacteremic infections with and without endocarditis carry a high risk for both stroke and acute myocardial infarction. During the last decade, chronic bacterial infections such as Chlamydia pneumoniae and dental infections have been associated as risk factors for various atherosclerotic diseases. These chronic bacterial infections are risk factors for acute cardiovascular events, but they may also have some role in the etiopathogenesis of atherosclerotic process itself. There are many known mechanisms that might explain the observed association of infection and atherosclerotic diseases, but it is probable that these mechanisms are complex and multifactorial and probably differ from infection to infection and from patient to patient. Infection theory is by no means against classic risk factor theory in the etiopathogenesis of atherosclerosis. Infection may also act as a synergistic risk factor together with classic risk factors in the development of various atherosclerotic diseases. (Am Heart J 1999;138:S431-S433.) Author Affiliation: Division of Infectious Diseases, Department of Medicine, Helsinki University Central Hospital. Helsinki, Finland Article Note: (footnote) [star] Reprint requests: Ville Valtonen, MD, Department of Medicine, Helsinki University Central Hospital, PL 340, 00029 HYKS, Helsinki, Finland., [star][star] 0002-8703/99/$8.00 + 0 4/0/101702

Published
1999

Catalog

Books, media, physical & digital resources
See catalog results